Technological developments in recent years, which include advances in image quality and improved diagnostic sensitivity, are broadening the options for diagnosing gastrointestinal (GI) conditions.
A Johns Hopkins University-led research team has developed a pill-sized capsule that, when swallowed by a patient, can diagnose, monitor, and treat gastrointestinal diseases including Barrett's ...
Failure to take meds as prescribed contributes to hundreds of thousands of preventable deaths annually. These capsules may ...
NEW YORK, May 31, 2018 /PRNewswire/ -- TechCare Corp. (OTCQB: TECR) ("TechCare"), today announced that following intensive R&D and investments, it has expanded its existing IP portfolio with a ...
$4.8 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to over $8 million New capital will support a worldwide commercial organisation, enabling a direct ...
In a recent study published in Science Robotics, a team of researchers led by the Massachusetts Institute of Technology (MIT) have developed a robotic drug capsule, which they dub “RoboCap”, designed ...
Thought LeadersAndrea DoolanCEO and co-founderAtlantia Food Clinical Trials In this interview, Andrea Doolan, CEO and co-founder of Atlantia Clinical Trials, describes a case study trial on ...